USA DOMESTIC STEROIDS 🇺🇸 (255 Offers)
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Methandienone Oral anabolic-androgenic steroid
50 mg per tablet
Form Oral Tablets
Packaging 100 Tablets
Estimated Half-Life Approximately 4–6 Hours
Detection Up to 5–6 Weeks
Liver Toxicity High
Water Retention High
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Oxymetholone Oral anabolic-androgenic steroid
50 mg per tablet
Form Oral Tablets
Packaging 50 Tablets
Estimated Half-Life Approximately 8–9 Hours
Detection Up to 2–3 Months
Liver Toxicity High
Water Retention High
Laboratory Tested
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Stanozolol Oral DHT-derived anabolic-androgenic steroid
10 mg per tablet
Form Oral Tablets
Packaging 100 Tablets
Estimated Half-Life Approximately 9 Hours
Detection Up to 5–6 Weeks
Liver Toxicity High
Water Retention Low
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance 4-Chlorodehydromethyltestosterone Oral anabolic-androgenic steroid
10 mg per tablet
Form Oral Tablets
Packaging 100 Tablets
Estimated Half-Life Approximately 16 Hours
Detection Up to 4–6 Weeks
Liver Toxicity Moderate
Water Retention None
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Anastrozole Oral aromatase inhibitor
1 mg per tablet
Form Oral Tablets
Packaging 50 or 100 Tablets
Estimated Half-Life Approximately 40–50 Hours
Detection Up to several weeks
Primary Mechanism Aromatase Inhibition
Estrogen Suppression High
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Exemestane Oral steroidal aromatase inhibitor
25 mg per tablet
Form Oral Tablets
Packaging 50 or 100 Tablets
Estimated Half-Life Approximately 24 Hours
Detection Up to several weeks
Primary Mechanism Irreversible Aromatase Inactivation
Estrogen Suppression High
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Letrozole Oral aromatase inhibitor
2.5 mg per tablet
Form Oral Tablets
Packaging 50 or 100 Tablets
Estimated Half-Life Approximately 2 Days
Detection Up to several weeks
Primary Mechanism Aromatase Inhibition
Estrogen Suppression Very High
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Tamoxifen Citrate Oral selective estrogen receptor modulator
20 mg per tablet
Form Oral Tablets
Packaging 50 or 100 Tablets
Estimated Half-Life Approximately 5–7 Days
Detection Up to several weeks
Primary Mechanism Mixed ER Agonist / Antagonist
HPTA Support High
Laboratory Tested
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Clenbuterol Hydrochloride Oral beta-2 adrenergic agonist
40 mcg per tablet
Form Oral Tablets
Packaging 100 Tablets
Estimated Half-Life Approximately 36–48 Hours
Detection Up to 4–6 Days (plasma)
Primary Mechanism Beta-2 Adrenergic Agonism
Thermogenic Effect High
Laboratory Tested
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Substance Oxandrolone Oral anabolic-androgenic steroid
10 mg per tablet
Form Oral Tablets
Packaging 100 Tablets
Estimated Half-Life Approximately 9 Hours
Detection Up to 15–18 Days
Liver Toxicity Moderate
Water Retention Low
Laboratory Tested
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Substance Ibutamoren Oral growth hormone secretagogue
25 mg per tablet
Form Oral Tablets
Packaging 100 Tablets
Estimated Half-Life Approximately 24 Hours
Detection Up to several weeks
Primary Mechanism Ghrelin Receptor Agonism
GH / IGF-1 Impact High
Laboratory Tested
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Substance Human Chorionic Gonadotropin Injectable gonadotropin (LH analogue)
5000 IU per vial
Form Lyophilized Powder
Packaging 2 mL Vial + 1 Amp Solvent
Estimated Half-Life Approximately 24–36 Hours
Detection Limited data · Up to several weeks
Primary Mechanism LH Receptor Agonism
HPTA / Testicular Support High
$145.00
Coming Soon!
Product Information
Dragon PharmaCompound Details
Active Substance KPV (Ac-Lys-Pro-Val-NH₂) Lyophilized anti-inflammatory tripeptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Sterile Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism Melanocortin Pathway / NF-κB Modulation
Anti-Inflammatory Impact High
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Substance Kisspeptin Lyophilized peptide hormone (KISS1 analogue)
10 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism KISS1R Agonism / Upstream GnRH Stimulation
HPTA / Gonadotropin Support High
You will save $56.00
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Substance MOTS-c Lyophilized mitochondrial-derived peptide (12S rRNA-c)
10 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism AMPK Activation / Mitochondrial Retrograde Signalling
Metabolic / Endurance Impact High
$84.00
$140.00
Product Information
Dragon PharmaCompound Details
Active Substance PE 22-28 Lyophilized PACAP-derived neuropeptide fragment
10 mg per vial
Form Lyophilized Powder
Packaging 2 mL Sterile Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism PACAP Receptor-Mediated Neuroprotection
Neuroprotective / Anti-Inflammatory Impact Moderate
